Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites

BACKGROUND: Malignant ascites often causes discomfort in advanced cancer patients. Paracentesis is the most common treatment modality, but it requires frequently repeated treatment. Cell-free and concentrated ascites reinfusion therapy (CART) may prolong the paracentesis interval, but controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokomichi, Naosuke, Imai, Kengo, Sakamoto, Masaki, Horiki, Masashi, Yamauchi, Toshihiro, Miwa, Satoru, Inoue, Satoshi, Uneno, Yu, Suzuki, Hidekazu, Wada, Toru, Ichikawa, Yuri, Morita, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883725/
https://www.ncbi.nlm.nih.gov/pubmed/35227250
http://dx.doi.org/10.1186/s12885-022-09336-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883725/
https://www.ncbi.nlm.nih.gov/pubmed/35227250
http://dx.doi.org/10.1186/s12885-022-09336-3

Ejemplares similares